Enter the MedStartr Launchathon — Aug 1–Oct 6 in NYC
< Back to companies

Preventing dyspnea in heart failure

Get Involved in 66-CellMetRx
Claim This Profile →

Company Info

Categories

Cardiovascular DiseasePreventionClinical InterventionsBiotech

Disease Areas

MedStartr Index Score

?
3

What do you think of 66-CellMetRx?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in 66-CellMetRx